Vericel Corp (VCEL)

• Market cap: $2.35B
• 1 day: -2.95%
• 5 days: -1.2%
• 1 month: 20.37%
• 3 months: 31.16%
• 6 months: 23.47%
• Year to date: 29.43%
• 1 year: 15.75%
• 5 years: -11.42%
• 10 years: 2,105.26%
• Sector: Healthcare
• Industry: Biotechnology

About: Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 398